Protein Sciences’ Zika Vaccine moves into Phase 1 trials

Protein Sciences reported that its protein based Zika vaccine candidate is expected to move on to human clinical trials by April. Also, the team developing the vaccine in Protein Sciences is now joined by the Institute of Technology in Immunobiological of the Oswaldo Cruz Foundation. The move…